These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 211909)

  • 21. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
    Ganguly A; Melada GA; Luetscher JA; Dowdy AJ
    J Clin Endocrinol Metab; 1973 Nov; 37(5):765-75. PubMed ID: 4356136
    [No Abstract]   [Full Text] [Related]  

  • 22. A sensitive radioimmunoassay for plasma ACTH levels.
    Demura H; West CD; Nugent CA; Nakagawa K; Tyler FH
    J Clin Endocrinol Metab; 1966 Dec; 26(12):1297-302. PubMed ID: 4289592
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
    Biglieri EG; Brust N; Chang B; Hirai J; Wajchenberg BL; Schambelan M
    Prog Biochem Pharmacol; 1980; 17():36-43. PubMed ID: 6259660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
    Fukuchi S; Takenouchi T; Nakajima K; Sasaki C
    Nihon Naibunpi Gakkai Zasshi; 1973 Jul; 49(7):981-7. PubMed ID: 4353327
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.
    Otsuka F; Otsuka-Misunaga F; Koyama S; Yamanari H; Ogura T; Ohe T; Makino H
    J Endocrinol Invest; 1998 Sep; 21(8):531-6. PubMed ID: 9801995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
    Biglieri EG; Schambelan M
    J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
    Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
    J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cortisol infusion on plasma renin activity, aldosterone levels and 11-deoxycorticosterone levels in humans (author's transl)].
    Sugawara T
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):710-8. PubMed ID: 689214
    [No Abstract]   [Full Text] [Related]  

  • 29. Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J; Messerli FH; Honda M; Tolis G; Seth K; Parvin-Pande R; Kubo S; Grose J; Ledoux F; Lebel M
    J Steroid Biochem; 1975 May; 6(5):767-78. PubMed ID: 171513
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
    Guthrie GP
    J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influences of ACTH, dietary sodium, upright posture and angiotensin II on plasma 18-hydroxy-11-deoxycorticosterone levels in normal subjects.
    Tuck ML; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1977 Nov; 45(5):893-902. PubMed ID: 200632
    [No Abstract]   [Full Text] [Related]  

  • 32. Preoperative diagnosis and localization of aldosteronomas by measurement of corticosteroids in adrenal venous blood.
    Dunnick NR; Doppman JL; Mills SR; Gill JR
    Radiology; 1979 Nov; 133(2):331-3. PubMed ID: 227011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
    Irony I; Kater CE; Biglieri EG; Shackleton CH
    Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tranylcypromine on adrenocortical secretion in the dog.
    Johnson PC; Lorenzen LC; Biglieri EG; Ganong WF
    Endocrinology; 1967 Mar; 80(3):510-4. PubMed ID: 4289899
    [No Abstract]   [Full Text] [Related]  

  • 35. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deoxycorticosterone production and regulation in man.
    Schambelan M; Biglieri EG
    J Clin Endocrinol Metab; 1972 Apr; 34(4):695-703. PubMed ID: 4335105
    [No Abstract]   [Full Text] [Related]  

  • 37. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases.
    Arteaga E; Biglieri EG; Kater CE; Lopez JM; Schambelan M
    Ann Intern Med; 1984 Sep; 101(3):316-21. PubMed ID: 6087704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of deoxycorticosterone-producing adrenal tumor].
    Komura T; Uekado Y; Suzuki A; Miyai M
    Hinyokika Kiyo; 1993 Feb; 39(2):145-9. PubMed ID: 8465688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ
    J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.